Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 171 institutions that hold shares in the stock, with a total of 43.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.07 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
402,595
shares
|
$9.8 Million
0.98% of portfolio
|
Q3 2025
Added 127.84%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
386,203
shares
|
$9.4 Million
0.01% of portfolio
|
Q3 2025
Added 103.9%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
356,615
shares
|
$8.68 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.34%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
328,419
shares
|
$7.99 Million
0.0% of portfolio
|
Q3 2025
Added 122.99%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
306,371
shares
|
$7.45 Million
0.03% of portfolio
|
Q3 2025
Reduced 0.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
303,785
shares
|
$7.39 Million
0.0% of portfolio
|
Q3 2025
Added 19.14%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
297,851
shares
|
$7.25 Million
0.04% of portfolio
|
Q3 2025
Added 36.32%
|
|
|
Atom Investors LP
Austin, TX |
Nov 14, 2025 Q3 2025 |
291,962
shares
|
$7.1 Million
0.45% of portfolio
|
Q3 2025
Reduced 8.07%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
282,412
shares
|
$6.87 Million
0.47% of portfolio
|
Q3 2025
Reduced 56.99%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
275,100
shares
|
$6.69 Million
0.01% of portfolio
|
Q3 2025
Added 620.16%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
261,401
shares
|
$6.36 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.36%
|
|
|
Rice Hall James & Associates, LLC
|
Oct 16, 2025 Q3 2025 |
259,143
shares
|
$6.3 Million
0.29% of portfolio
|
Q3 2025
Reduced 9.98%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
204,191
shares
|
$4.97 Million
0.0% of portfolio
|
Q3 2025
Reduced 11.82%
|
|
|
Privium Fund Management B.V.
|
Nov 03, 2025 Q3 2025 |
196,622
shares
|
$4.78 Million
0.7% of portfolio
|
Q3 2025
Added 82.7%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2025 Q3 2025 |
190,452
shares
|
$4.63 Million
0.02% of portfolio
|
Q3 2025
Reduced 44.98%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2025 Q3 2025 |
184,382
shares
|
$4.49 Million
0.01% of portfolio
|
Q3 2025
Reduced 29.57%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
180,460
shares
|
$4.39 Million
0.0% of portfolio
|
Q3 2025
Reduced 41.51%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
162,259
shares
|
$3.95 Million
0.0% of portfolio
|
Q3 2025
Added 559.38%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
147,225
shares
|
$3.58 Million
0.0% of portfolio
|
Q3 2025
Reduced 69.63%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
135,000
shares
|
$3.28 Million
0.48% of portfolio
|
Q3 2025
New holding
|
|
|
Hrt Financial LP
New York, NY |
Nov 14, 2025 Q3 2025 |
133,674
shares
|
$3.25 Million
0.01% of portfolio
|
Q3 2025
Added 28.25%
|
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Nov 12, 2025 Q3 2025 |
126,720
shares
|
$3.08 Million
0.02% of portfolio
|
Q3 2025
Reduced 23.71%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
125,969
shares
|
$3.06 Million
0.0% of portfolio
|
Q3 2025
Added 2.12%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
125,298
shares
|
$3.05 Million
0.0% of portfolio
|
Q3 2025
Reduced 20.72%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
116,436
shares
|
$2.83 Million
0.03% of portfolio
|
Q3 2025
New holding
|
|